Literature DB >> 27822908

The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles.

N Purandare1,2, G Emerson3, C Kirkham3, C Harrity4, D Walsh4, E Mocanu3.   

Abstract

BACKGROUND: Ovarian stimulation is an essential part of assisted reproduction treatments. Research on whether the duration of stimulation alters the success in assisted reproduction has not been conclusive. AIM: The purpose of the study was to establish whether the duration of ovarian stimulation alters the success in assisted reproduction treatments.
METHODS: All fresh (non-donor) stimulation cycles performed in an academic tertiary referral ART centre over a period of 18 years, between 1st January 1997 and 31st December 2014, were identified. Data were prospectively and electronically collected. IVF and ICSI cycles were analysed independently. Each category was then subdivided into assisted reproduction cycles where the antagonist, long (down regulation) and flare protocol were used. Clinical pregnancy was the main outcome measured. A total of 10,478 stimulation cycles (6011 fresh IVF and 4467 fresh ICSI) reaching egg collection were included.
RESULTS: We showed no significant difference in CP rates in IVF cycles for the long (p = 0.082), antagonist (p = 0.217) or flare (p = 0.741) protocol cycles or in ICSI cycles with the long (p = 0.223), antagonist (p = 0.766) or the flare (p = 0.690) protocol with regards the duration of stimulation.
CONCLUSION: The duration of stimulation does not alter the CP rate in ICSI or IVF cycles using the long, antagonist or flare stimulation protocol.

Entities:  

Keywords:  ART (assisted reproductive technology); Clinical pregnancy (CP); Gonadotropin; ICSI (intra-cytoplasmic sperm injection); IVF (in vitro fertilization)

Mesh:

Substances:

Year:  2016        PMID: 27822908     DOI: 10.1007/s11845-016-1526-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

1.  Prolonged gonadotropin stimulation is associated with decreased ART success.

Authors:  Meleen Chuang; Athena Zapantis; Martina Taylor; Sangita K Jindal; Genevieve S Neal-Perry; Harry J Lieman; Alex Joel Polotsky
Journal:  J Assist Reprod Genet       Date:  2010-09-07       Impact factor: 3.412

2.  Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.

Authors:  Valerie L Baker; Barbara Luke; Morton B Brown; Ruben Alvero; John L Frattarelli; Rebecca Usadi; David A Grainger; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2009-09-09       Impact factor: 7.329

3.  In vitro fertilisation treatment and factors affecting success.

Authors:  Jack Yu Jen Huang; Zev Rosenwaks
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-10-09       Impact factor: 5.237

4.  Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure.

Authors:  F Bonilla-Musoles; J C Castillo; O Caballero; J Pérez-Panades; F Bonilla; M Dolz; N Osborne
Journal:  Clin Exp Obstet Gynecol       Date:  2012       Impact factor: 0.146

5.  The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.

Authors:  D L Hock; H Louie; R M Shelden; C V Ananth; E Kemmann
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

6.  [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].

Authors:  Shi-ling Chen; Ling Sun; Ling-hong Kong; Li Li; Jin Li; Liang Zhu; Tian-ming Gao; Fu-qi Xing
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2007-08

7.  Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.

Authors:  J S Martin; J A Nisker; I S Tummon; S A Daniel; J L Auckland; V Feyles
Journal:  Fertil Steril       Date:  1996-06       Impact factor: 7.329

8.  What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?

Authors:  Nivin Samara; Daniel Reis; Netanella Danielli Miller; Yehudith Ghetler; Arie Berkovitz; Moses Miller; Ofer Gonen; Adrian Shulman; Amir Wiser
Journal:  Gynecol Endocrinol       Date:  2015-09-29       Impact factor: 2.260

Review 9.  Effect of overweight and obesity on assisted reproductive technology--a systematic review.

Authors:  A Maheshwari; Lawrize Stofberg; S Bhattacharya
Journal:  Hum Reprod Update       Date:  2007-06-21       Impact factor: 15.610

Review 10.  GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis.

Authors:  M A F Youssef; Hatem I Abdelmoty; Mohamed A S Ahmed; Maged Elmohamady
Journal:  J Adv Res       Date:  2015-01-21       Impact factor: 10.479

View more
  1 in total

1.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.